Article
Radiology, Nuclear Medicine & Medical Imaging
Jose Pablo Pedraza-Sanchez, Reyes Chaves-Marcos, Javier Mazuecos-Quiros, alvaro Luis Bisono-Castillo, Ignacio Osman-Garcia, Carlos Miguel Gutierrez-Marin, Rafael Antonio Medina Lopez, Alvaro Juarez Soto
Summary: This study compared the efficacy, safety, and oncological outcomes of percutaneous radiofrequency ablation (PRFA) and partial nephrectomy (PN) for small renal masses (SRMs). The results showed that PRFA is non-inferior to PN in terms of oncological outcomes and safety, particularly for high-risk patients.
EUROPEAN RADIOLOGY
(2023)
Article
Urology & Nephrology
Gabriele Sorce, Benedikt Hoeh, Lukas Hohenhorst, Andrea Panunzio, Stefano Tappero, Zhe Tian, Andrea Kokorovic, Alessandro Larcher, Umberto Capitanio, Derya Tilki, Carlo Terrone, Felix K. H. Chun, Alessandro Antonelli, Fred Saad, Shahrokh F. Shariat, Francesco Montorsi, Alberto Briganti, Pierre I. Karakiewicz
Summary: This study found that local tumor destruction (LTD) treatment for T1a renal cell carcinoma (RCC) patients is associated with higher cancer-specific mortality (CSM) compared to partial nephrectomy (PN) treatment, especially for patients with tumor size between 3.1 and 4 cm.
EUROPEAN UROLOGY FOCUS
(2023)
Article
Urology & Nephrology
Braden Millan, Rodney H. Breau, Bimal Bhindi, Ranjeeta Mallick, Simon Tanguay, Antonio Finelli, Luke T. Lavallee, Frederic Pouliot, Ricardo Rendon, Alan I. So, Lucas Dean, Jean-Baptiste Lattouf, Naveen S. Basappa, Anil Kapoor
Summary: The purpose of this study was to compare the efficacy of percutaneous ablation therapy (AT) and partial nephrectomy (PN) for T1a renal cancer. The results showed that although there was no significant difference in overall survival (OS) between AT and PN, PN performed better in terms of recurrence-free survival (RFS). Therefore, both treatment modalities can be offered to appropriately selected patients.
JOURNAL OF UROLOGY
(2022)
Review
Surgery
Vinson Wai-Shun Chan, Ahmad Abul, Filzah Hanis Osman, Helen Hoi-Lam Ng, Kaiwen Wang, Yuhong Yuan, Jon Cartledge, Tze Min Wah
Summary: This review compared the oncological outcomes of ablative therapies (AT) and partial nephrectomy (PN) in patients with small renal masses (SRM). It found that while AT patients in the T1a group had worse overall survival, they experienced fewer post-operative complications, better kidney function preservation, and similar cancer-specific survival compared to PN patients. Further long-term high-quality studies are needed to confirm the potential benefits of AT, especially in T1b patients.
INTERNATIONAL JOURNAL OF SURGERY
(2022)
Article
Urology & Nephrology
Lorenzo Bianchi, Federico Mineo Bianchi, Francesco Chessa, Umberto Barbaresi, Carlo Casablanca, Pietro Piazza, Angelo Mottaran, Matteo Droghetti, Carlo Roveroni, Eleonora Balestrazzi, Giorgio Gentile, Caterina Gaudiano, Alessandro Bertaccini, Emanuela Marcelli, Angelo Porreca, Bernardino De Concilio, Carla Serra, Antonio Celia, Eugenio Brunocilla, Riccardo Schiavina
Summary: Partial nephrectomy (PN) had higher recurrence-free survival rates compared to radiofrequency ablation (RFA) and cryoablation (Cryo) in patients with T1 renal cell carcinoma, especially in those with clear cell RCC and tumors of 2-4 cm. In patients with non-clear cell RCC and tumors <2cm, PN also showed better recurrence-free survival rates. Ablative techniques (RFA and Cryo) were independent predictors of recurrence, with recurrence rates and other causes of mortality varying among the different treatment modalities.
MINERVA UROLOGY AND NEPHROLOGY
(2021)
Review
Oncology
Hongchen Qu, Kai Wang, Bin Hu
Summary: To systematically review the differences between radiofrequency ablation and partial nephrectomy in patients with early-stage renal cell carcinoma, and provide evidence-based medical evidence for surgical choice. The study demonstrates the advantages of radiofrequency ablation in early-stage renal cell carcinoma.
FRONTIERS IN ONCOLOGY
(2023)
Article
Medicine, General & Internal
Lorenzo Bertolotti, Federica Segato, Francesco Pagnini, Sebastiano Buti, Andrea Casarin, Antonio Celia, Francesco Ziglioli, Umberto Maestroni, Giuseppe Pedrazzi, Velio Ascenti, Chiara Martini, Calogero Cicero, Massimo De Filippo
Summary: The efficacy and complication rates of percutaneous radiofrequency ablation (RFA) and cryoablation (CA) in the treatment of T1 renal masses were retrospectively investigated. The results showed that both RFA and CA were effective in treating renal masses, with rare major complications.
Article
Radiology, Nuclear Medicine & Medical Imaging
Raphael Lehrer, Francois Cornelis, Jean-Christophe Bernhard, Pierre Bigot, Cecile Champy, Franck Bruyere, Morgan Roupret, Nicolas Doumerc, Charles-Karim Bensalah, Jonathan Olivier, Francois Audenet, Thibault Tricard, Bastien Parier, Xavier Durand, Matthieu Durand, Thomas Charles, Nicolas Branger, Louis Surlemont, Evanguelos Xylinas, Jean-Baptiste Beauval, Matthias Barral
Summary: This study compared the oncological and perioperative outcomes of robot-assisted partial nephrectomy (RPN) and percutaneous thermal ablation (PTA) for T1 renal cell cancer (RCC) in elderly patients. The results showed similar oncological outcomes between PTA and RPN in elderly patients.
EUROPEAN RADIOLOGY
(2023)
Article
Urology & Nephrology
Braden Millan, Rodney H. Breau, Bimal Bhindi, Ranjeeta Mallick, Simon Tanguay, Antonio Finelli, Luke T. Lavallee, Frederic Pouliot, Ricardo Rendon, Alan I. So, Lucas Dean, Jean-Baptiste Lattouf, Naveen S. Basappa, Anil Kapoor
Summary: This study compared the efficacy of percutaneous ablation therapy and partial nephrectomy in the treatment of T1a renal cancer. The results showed that partial nephrectomy had better recurrence-free survival, while there was no significant difference in overall survival.
JOURNAL OF UROLOGY
(2022)
Article
Gastroenterology & Hepatology
Satoshi Ogiso, Satoru Seo, Yuji Eso, Tomoaki Yoh, Takayuki Kawai, Shinya Okumura, Takamichi Ishii, Ken Fukumitsu, Kojiro Taura, Hiroshi Seno, Shinji Uemoto
Summary: This study compared the outcomes of minor liver resections (LLR) and radiofrequency ablation (RFA) for small hepatocellular carcinomas, finding that LLR provides better local control with higher recurrence-free and local recurrence-free survival rates, but also comes with higher incidence of complications and longer hospital stays.
Article
Surgery
Hong Jae Jeon, Hyuk Soo Eun, In Sun Kwon, Byung Seok Lee, Eaum Seok Lee, Woo Sun Rou, Jae Kyu Sung, Hee Seok Moon, Sun Hyung Kang, Hyun Seok Lee, Seok-Hwan Kim, Kwangsik Chun, Seok Hyun Kim
Summary: This study compared the therapeutic outcomes of laparoscopic radiofrequency ablation (LRFA) and percutaneous radiofrequency ablation (PRFA) in patients with hepatocellular carcinoma (HCC). The results revealed that LRFA was associated with longer recurrence-free survival and favorable overall survival compared to PRFA. Therefore, LRFA should be considered as the primary therapy for eligible HCC patients.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Vinson Wai-Shun Chan, Filzah Hanis Osman, Jon Cartledge, Walter Gregory, Michael Kimuli, Naveen S. Vasudev, Christy Ralph, Satinder Jagdev, Selina Bhattarai, Jonathan Smith, James Lenton, Tze Min Wah
Summary: A retrospective study compared the long-term and peri-operative outcomes of image-guided ablation (IGA) and laparoscopic partial nephrectomy (LPN) in localized RCC patients. The study found that IGA had better local recurrence-free survival (LRFS) and metastasis-free survival compared to LPN, and also preserved kidney function better post-operatively.
EUROPEAN RADIOLOGY
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Steven D. Kao, Siddharth A. Padia, John M. Moriarty, Ravi N. Srinivasa
Summary: This study describes a method of using a balloon-occlusion catheter and microwave ablation to treat a hypervascular adrenal metastasis.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY
(2022)
Letter
Medicine, General & Internal
Aparna Sharma, Ranjit K. Sahoo, Atul Batra, Archie Bleyer, Toni K. Choueiri, Thomas Powles
Summary: Adding adjuvant pembrolizumab after nephrectomy can significantly improve disease-free survival in patients with renal-cell carcinoma, but there are concerns regarding the arbitrary duration of 12 months of adjuvant treatment. Many patients discontinued treatment due to adverse events.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Joel Wessendorf, Alexander Konig, Hendrik Heers, Andreas H. Mahnken
Summary: The study found that radiofrequency ablation (RFA) is safe and effective for treating renal cell carcinomas in patients with Von Hippel-Lindau disease, and can preserve sufficient renal function even after renal surgery, with low risk of recurrence.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
(2021)
Review
Public, Environmental & Occupational Health
Bo Gong, Mohammed F. Mohammed, Savvas Nicolaou, Muazzam Nasrullah, Bruce B. Forster, Faisal Khosa
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
(2018)
Article
Radiology, Nuclear Medicine & Medical Imaging
Bo Gong, James P. Nugent, William Guest, William Parker, Paul J. Chang, Faisal Khosa, Savvas Nicolaou
ACADEMIC RADIOLOGY
(2019)
Review
Clinical Neurology
Bo Gong, Sadiq Naveed, Dawood M. Hafeez, Khalid I. Afzal, Salman Majeed, Jonathan Abele, Savvas Nicolaou, Faisal Khosa
JOURNAL OF NEUROIMAGING
(2019)
Letter
Radiology, Nuclear Medicine & Medical Imaging
Bo Gong, James P. Nugent, William Guest, William Parker, Paul J. Chang, Faisal Khosa, Savvas Nicolaou
ACADEMIC RADIOLOGY
(2019)
Article
Multidisciplinary Sciences
Yuan Ge, Meng Tian, Lidong Liu, Tak Pan Wong, Bo Gong, Dongchuan Wu, Taesup Cho, Shujun Lin, Jurgen Kast, Jie Lu, Yu Tian Wang
NATURE COMMUNICATIONS
(2019)
Letter
Radiology, Nuclear Medicine & Medical Imaging
Bo Gong, Fateme Salehi
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES
(2022)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Bo Gong, Fateme Salehi, Casey Hurrell, Michael N. Patlas
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES
(2022)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Bo Gong, Philippe Soyer, Matthew D. F. McInnes, Michael N. Patlas
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES
(2023)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Bo Gong, Michael N. Patlas
DIAGNOSTIC AND INTERVENTIONAL IMAGING
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
William Tanguay, Philippe Acar, Benjamin Fine, Mohamed Abdolell, Bo Gong, Alexandre Cadrin-Chenevert, Carl Chartrand-Lefebvre, Jean Chalaoui, Andrei Gorgos, Anne Shu-Lei Chin, Julie Prenovault, Francois Guilbert, Laurent Letourneau-Guillon, Jaron Chong, An Tang
Summary: Artificial intelligence (AI) software in radiology is becoming more widespread and improving rapidly. However, there is a need for recommendations on assessing AI software before adoption and after commercialization. To address this, a glossary of AI software types, use cases, and roles, as well as a framework for software evaluation, has been proposed to facilitate communication with the AI software industry and aid decision-making in healthcare.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES
(2023)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Bo Gong, Michael N. N. Patlas
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Bo Gong, Philippe Soyer, Matthew D. F. Mcinnes, Michael N. Patlas
Summary: This study investigated intra-specialty citation patterns of radiology and gastroenterology/hepatology articles and found that radiology articles had lower intra-specialty citation counts, which may contribute to the lower impact factors of radiology journals compared with gastroenterology/hepatology ones.
CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES
(2023)
Article
Neuroimaging
Ezequiel Gleichgerrcht, Brent C. Munsell, Saud Alhusaini, Marina K. M. Alvim, Nuria Bargallo, Benjamin Bender, Andrea Bernasconi, Neda Bernasconi, Boris Bernhardt, Karen Blackmon, Maria Eugenia Caligiuri, Fernando Cendes, Luis Concha, Patricia M. Desmond, Orrin Devinsky, Colin P. Doherty, Martin Domin, John S. Duncan, Niels K. Focke, Antonio Gambardella, Bo Gong, Renzo Guerrini, Sean N. Hatton, Reetta Kalviainen, Simon S. Keller, Peter Kochunov, Raviteja Kotikalapudi, Barbara A. K. Kreilkamp, Angelo Labate, Soenke Langner, Sara Lariviere, Matteo Lenge, Elaine Lui, Pascal Martin, Mario Mascalchi, Stefano Meletti, Terence J. O'Brien, Heath R. Pardoe, Jose C. Pariente, Jun Xian Rao, Mark P. Richardson, Raul Rodriguez-Cruces, Theodor Ruber, Ben Sinclair, Hamid Soltanian-Zadeh, Dan J. Stein, Pasquale Striano, Peter N. Taylor, Rhys H. Thomas, Anna Elisabetta Vaudano, Lucy Vivash, Felix von Podewills, Sjoerd B. Vos, Bernd Weber, Yi Yao, Clarissa Lin Yasuda, Junsong Zhang, Paul M. Thompson, Sanjay M. Sisodiya, Carrie R. McDonald, Leonardo Bonilha
Summary: The study utilized machine learning and artificial intelligence models to classify and diagnose TLE patients based on brain MRI data, showing more accurate differentiation between lesional and non-lesional patients. Structural and diffusion-based models demonstrated similar classification accuracies.
NEUROIMAGE-CLINICAL
(2021)
Meeting Abstract
Rheumatology
Juvel Lee, Waleed Abdellatif, Sunghan Jung, Ahmed Negida, Bo Gong, Savvas Nicolaou
ANNALS OF THE RHEUMATIC DISEASES
(2019)
Meeting Abstract
Rheumatology
Bo Gong, Mark Warwas, Michael O'keeffe, Nicole Tsao, Mary De Vera, Kamran Shojania, Faisal Khosa, Savvas Nicolaou
ANNALS OF THE RHEUMATIC DISEASES
(2019)